BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//International Health Economics Association - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:International Health Economics Association
X-ORIGINAL-URL:https://healtheconomics.org
X-WR-CALDESC:Events for International Health Economics Association
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260505T143000
DTEND;TZID=UTC:20260505T153000
DTSTAMP:20260507T040219
CREATED:20260423T142813Z
LAST-MODIFIED:20260423T151309Z
UID:335013-1777991400-1777995000@healtheconomics.org
SUMMARY:Do changes in management practices reduce hospital waiting times? Evidence from a workforce retention programme
DESCRIPTION:Add to Calendar! \nLong before the pandemic\, increasingly longer waiting times for hospital treatment in English NHS has been a challenge\, directly affecting patient outcomes\, service efficiency\, and overall healthcare quality. In this paper\, we develop a theoretical model that links patients’ waiting times for planned treatment to hospital nurses’ retention\, and postulate the possibility of a virtuous loop between these two variables that can be ignited by higher managerial quality. We test these hypotheses by assessing the effects of a national workforce policy on waiting times\, leveraging a synthetic difference-in-difference analysis using detailed patient records for planned care admissions to English NHS hospitals.\nIn line with the predictions\, our results suggest that the policy had indeed improved nurses’ retention\, while also leading to reductions in average waiting times for planned knee replacement surgery and shortens waiting times for all planned procedures. Our results highlight the potential benefits of workforce stability and managerial improvements on healthcare delivery. \nSpeaker: \n \nGiuseppe is a Professor of Economics at the University of Surrey and an empirical economist specialising in health economics\, labour economics\, and applied micro-econometrics. He previously held research positions at the Centre for Health Economics\, University of York\, and before his PhD he has worked in investment banking at Lehman Brothers in London. Giuseppe earned his PhD in Econometrics and Empirical Economics from the University of Rome Tor Vergata\, following undergraduate and master’s degrees from Bocconi University in Milan. \nHis research focuses on generating robust causal evidence to inform health and workforce policy\, with particular expertise in provider choice and competition\, hospital performance\, waiting times\, health inequalities in access to healthcare\, and the economics of the healthcare workforce. From 2019 to 2025\, Giuseppe has been the Principal Investigator of a major Health Foundation–funded programme examining the determinants and impacts of hospital workforce retention in the English NHS. His work is widely published in leading health economics and social science journals.
URL:https://healtheconomics.org/event/do-changes-in-management-practices-reduce-hospital-waiting-times-evidence-from-a-workforce-retention-programm/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260504T153000
DTEND;TZID=UTC:20260504T163000
DTSTAMP:20260507T040219
CREATED:20260423T162906Z
LAST-MODIFIED:20260423T163130Z
UID:335019-1777908600-1777912200@healtheconomics.org
SUMMARY:Do GLP-1 Medications Pay for Themselves?
DESCRIPTION:Add to Calendar! \nGlucagon-like peptide-1 receptor agonists (GLP-1s) represent a major improvement in treatment of diabetes\, obesity\, and cardiovascular risk reduction\, but they are also among the most expensive drugs in widespread use and the subject of significant policy debate. The high price of these drugs may overstate their net cost if the health improvements they produce lead to reduced downstream health care use and medical spending\, that is\, cost offsets. We estimate such offsets using insurance claims data\, examining the effects of GLP-1 initiation on subsequent GLP-1 use and spending\, and on other non-GLP-1 spending. We use a stacked difference-in-differences design\, comparing patients initiating GLP-1 medication to not-yet-treated controls who initiate GLP-1s several months or years later\, allowing us to control for underlying time trends and baseline characteristics. Overall\, we do not find a reduction in downstream medical spending. Although GLP-1 initiation reduces spending on other diabetes medications\, total non-GLP-1 spending increases\, driven by higher outpatient health care use; GLP- 1 drug spending rises mechanically. For health care payers\, the relevant cost of GLP-1 initiation therefore extends beyond the sticker price of the drug. We find similar results across subgroups of GLP1 initiators including those with prior cardiovascular disease and those without diabetes (consistent with obesity indication). Our main results examine spending responses over the first year after initiation. However\, we also estimate longer run effects in a smaller sample and find no cost offsets even five years after GLP-1 initiation. Taken together\, these results suggest that payers facing the costs of GLP-1 coverage are unlikely to see large savings from reduced spending on other care. If GLP-1 therapies ultimately yield cost savings\, they are likely to occur only over longer horizons or through non-medical channels. \nSpeaker: \nDr. Kosali Simon is the Herman B Wells Endowed Professor at Indiana University. In 2021\, she was elected to the National Academy of Medicine. Simon is a nationally known health economist who specializes in applying economic analysis in the context of health insurance and health care policy. Her current research mainly focuses on the impact of health insurance reform on healthcare and labor market outcomes\, and on the causes and consequences of the opioid crisis. She is also active in national leadership roles in her profession\, serving on several boards and in editorial positions. A summary of her recent research appears in the 2018 National\nBureau of Economic Research Reporter.
URL:https://healtheconomics.org/event/do-glp-1-medications-pay-for-themselves/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260428T140000
DTEND;TZID=UTC:20260428T150000
DTSTAMP:20260507T040219
CREATED:20260402T152906Z
LAST-MODIFIED:20260407T180713Z
UID:334848-1777384800-1777388400@healtheconomics.org
SUMMARY:A new approach to comparing EQ-5D-5L value sets: What really makes a difference to people?
DESCRIPTION:Add to Calendar! \nBackground\nEQ-5D-5L value sets play a vital role worldwide in health technology assessment and measuring population health. However\, it is difficult to compare the impact of using different value sets\, for example if an older value set is replaced by a new one\, or if two or more value sets are available. \nObjectives\n1) Reformulating the standard EQ-5D-5L health-state utility model in terms of meaningful\, interpretable parameters: range of utility from best to worst state\, relative importance of each dimension\, and decrements associated with levels 2-4 as a fraction of the level 5 decrement;\n2) Providing formulae for the marginal effects of the reformulated model’s parameters on utilities;\n3) Empirically estimating marginal effects for several value sets and patient groups. \nData and Methods\nThe 2017/8 Health Surveys for England collected EQ-5D-5L responses from around 13\,000 people. Participants with a long-term condition were divided into patient groups according to how the condition affected them (vision/mobility/mental health/etc.). Participants with long-lasting pain were divided into groups of varying severity using the Chronic Pain Grade Scale (CPGS). The marginal effects of parameters from 48 EQ-5D-5L value sets were calculated for each patient group. In countries with multiple value sets available\, differences in parameters were compared to differences in mean utility. \nResults\nParameters representing value set range had consistently large marginal effects across value sets and patient groups. Increased importance of self-care relative to other dimensions always increased utility\, though with variable effect sizes. The direction and magnitude of the marginal effects of other dimensions’ relative importance varied across value sets and patient groups. The magnitude of all parameters’ marginal effects increased with condition severity.\nIn within-country comparisons the magnitudes of parameter differences were related to utility differences\, with the smallest and largest differences for both seen when comparing the Japanese and Peruvian value sets respectively. Utility differences were increasing in disease severity: the utility of people with the worst chronic pain level differed by 0.425 depending on which Peruvian value set was used. \nConclusion\nThis study presents innovative methods for comparing EQ-5D-5L value sets and assessing what aspects have the biggest impact on patient utilities. Value set range was a major driver of utility differences\, and people with more severe conditions were most likely to be impacted by using alternative value sets. \nSpeaker: \nEd Webb is an associate professor at the Academic Unit of Health Economics\, University of Leeds. He studies preferences and decision-making in a wide variety of contexts and using a range of methods. His other research interests include the measurement and valuation of health\, as well as interactions between health\, work and wellbeing.
URL:https://healtheconomics.org/event/a-new-approach-to-comparing-eq-5d-5l-value-sets-what-really-makes-a-difference-to-people/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260413T153000
DTEND;TZID=UTC:20260413T163000
DTSTAMP:20260507T040219
CREATED:20260402T144334Z
LAST-MODIFIED:20260402T153005Z
UID:334843-1776094200-1776097800@healtheconomics.org
SUMMARY:Culture and Health
DESCRIPTION:Add to Calendar! \nThis webinar explores the multifaceted relationship between culture and health from an economic perspective\, integrating insights from anthropology\, psychology\, and political science. It begins by examining how culture provides meaning to illness and suffering and explores how culturally grounded “disease theory systems” influence beliefs about what causes illness\, how and whether suffering should be remedied\, and the appropriate role of the state in allocating health care resources. The importance of culture in defining the boundary between normal and abnormal pathology is highlighted via case studies. The chapter next reviews evidence on how health behaviors such as smoking\, firearm ownership\, dietary practices\, and reproductive decisions are influenced by cultural norms of masculinity and religiosity. Lastly\, it examines how firms\, governments\, and civil society leverage and advance cultural narratives to influence individual behavior and public policy. Thus\, culture in relation to health both naturally evolves and is actively constructed\, with implications for health inequality and health policy. \nSpeaker:  \nMarcella Alsan is a physician-economist studying the economics of health inequality domestically and internationally. She is Associate Editor at the Journal of Economic Literature and Co-Chair of the Health Care Delivery Initiative of Abdul Latif Jameel Poverty Action Lab at MIT. She is co-recipient of the 2019 Arrow Award for Best Paper in Health Economics\, the 2021 William G. Manning Memorial Award for the Best Research in Health Econometrics\, recipient of a MacArthur Fellowship and was elected into the National Academy of Medicine in 2022. She co-directs the Health Inequality Lab at Harvard Kennedy School of Government.
URL:https://healtheconomics.org/event/culture-and-health/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260409T070000
DTEND;TZID=UTC:20260409T080000
DTSTAMP:20260507T040219
CREATED:20260305T182347Z
LAST-MODIFIED:20260305T182347Z
UID:334784-1775718000-1775721600@healtheconomics.org
SUMMARY:Showcasing ECR Research in Health Economics: BRCA Screening Webinar
DESCRIPTION:Add to Calendar! \nThis webinar will feature presentations from Dr Xia Wei (Postdoctoral Researcher\, Peking University)and Mackenzie Bourke (PhD Candidate and Research Fellow\, University of Melbourne). They will present their research on the economic evaluation of BRCA screening strategies\, including implications for prevention policy and resource allocation. \nEconomic evaluation of genetic testing and management strategies for breast and ovarian cancer\nThis presentation will present cost-effectiveness evidence on genetic testing and management strategies for breast and ovarian cancer. It will cover economic evaluations of unselected and population-based genetic testing\, and gene-specific prevention options (including cancer screening\, medical prevention\, and risk-reducing surgery) across different risk groups and settings. The analysis considers long-term health outcomes\, costs\, and quality-of-life impacts\, and discusses the implications for management pathways and resource allocation decision-making for breast and ovarian cancer. \nIntegrating individual-level preferences into an economic evaluation of genomic screening\nSuccessful implementation of genomic screening for the management of breast and ovarian cancer depends on uptake of genetic testing\, preventative therapies\, and intensified surveillance programs. Where economic evaluations have incorporated patient preferences\, these have typically been applied inconsistently and primarily at the cohort level. This study integrates discrete choice experiment data within a discrete-event simulation to predict individual-level preferences and estimate their impact on costs and health outcomes. Preliminary results suggest that incorporating individual preferences has only a marginal impact on average cost-effectiveness outcomes\, but a larger effect on subgroup-level cost-effectiveness results\, which may have important distributional implications. \nSpeakers:  \nXia Wei – Postdoctoral fellow\, School of Public Health\, Peking University\nXia Wei is a postdoctoral fellow at the School of Public Health\, Peking University. She received her PhD from the London School of Hygiene & Tropical Medicine. Her research focuses on health economics\, health technology assessment\, and evidence-based decision-making in cancer prevention and control. She has published more than 26 full-text publications in peer-review journals\, including JAMA Oncology and JAMA Network Open. \n  \n  \n  \n  \nMackenzie Bourke – PhD Candidate\, Economics of Genomics and Precision Medicine Unit\, University of Melbourne\nMac is a PhD candidate and research assistant in the Economics of Genomics and Precision Medicine Unit at the Melbourne School of Population and Global Health\, University of Melbourne. His research focuses on the economic modelling of genomic technologies for cancer and on advancing methodological approaches to better capture the value of genomic medicine in health economic evaluation. His work also examines quality-of-life outcomes among people living with rare conditions and their careers\, with the aim of improving how these impacts are measured and incorporated into economic evaluations and policy decisions relating to genomic and precision medicine.
URL:https://healtheconomics.org/event/showcasing-ecr-research-in-health-economics-brca-screening-webinar/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260318
DTEND;VALUE=DATE:20260321
DTSTAMP:20260507T040219
CREATED:20251116T011013Z
LAST-MODIFIED:20251116T011013Z
UID:334353-1773792000-1774051199@healtheconomics.org
SUMMARY:Fifth Ireland Masterclass in Health Economics
DESCRIPTION:See more details here! \nVenue: University of Galway\, Ireland.\nAt the Ireland Masterclass in Health Economics\, internationally prominent senior researchers share their cutting-edge research with early-career health economists (assistant professors\, post-doctoral researchers\, and PhD students). The event also includes professional development sessions\, such as a “Meet the Editors” event to discuss publication strategies with the editors of health economics journals and “Meet Employers” event to hear about opportunities in industry.
URL:https://healtheconomics.org/event/fifth-ireland-masterclass-in-health-economics/
CATEGORIES:External Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260313T080000
DTEND;TZID=UTC:20260313T090000
DTSTAMP:20260507T040219
CREATED:20260209T184017Z
LAST-MODIFIED:20260209T184017Z
UID:334716-1773388800-1773392400@healtheconomics.org
SUMMARY:Teaching Health Economics SIG Networking Event
DESCRIPTION:Add to Calendar! \nAn interactive networking event for SIG members to exchange ideas\, discuss current themes and challenges in higher education\, and help shape future SIG activities and events. \n 
URL:https://healtheconomics.org/event/teaching-health-economics-sig-networking-event-2/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260305T160000
DTEND;TZID=UTC:20260305T170000
DTSTAMP:20260507T040219
CREATED:20260203T222800Z
LAST-MODIFIED:20260203T222800Z
UID:334705-1772726400-1772730000@healtheconomics.org
SUMMARY:Building a Data System for Health and Labor Economics Research: The U.S. National Dementia Workforce Study
DESCRIPTION:Add to Calendar! \nThe growing prevalence of dementia in the United States underscores an urgent need to understand and strengthen the workforce providing this specialized care. This seminar presents findings from the National Dementia Workforce Study\, sponsored by the U.S. National Institute on Aging. This is the first large-scale\, annual survey program systematically tracking the dementia care workforce in America. \nThrough comprehensive annual surveys and linked administrative and clinical data sources\, this research initiative provides unprecedented insights into workforce composition\, training\, turnover\, retention\, and quality of life among dementia care workers across multiple care settings. We will discuss emerging findings on how workforce characteristics and practices influence care quality\, person-centered outcomes\, and financial sustainability of dementia care services. \nCritically\, this seminar highlights opportunities for health services researchers\, health economists\, and policy analysts to advance the field. All survey data and linked data sources are freely available to the research community\, enabling investigators to address key questions about workforce determinants of care quality\, cost-effectiveness of different staffing models\, and evidence-based strategies to build a sustainable dementia care workforce. \nWe welcome researchers and stakeholders interested in understanding how investment in workforce development translates to better health and economic outcomes for people living with dementia and their families. \nSpeaker: \n \nDr. Joanne Spetz – Professor\, University of California – San Francisco. Joanne Spetz is Director and Brenda and Jeffrey L. Kang Presidential Chair in Health Care Financing at the Philip R. Lee Institute for Health Policy Studies (IHPS)\, University of California San Francisco. IHPS is a 50-year-old organization that conducts innovative research to support\, guide\, and enable policymakers\, communities\, and clinicians in making evidence-informed decisions that improve health and health care for individuals and families. \nDr. Spetz’s research focuses on the economics of the health care workforce\, organization of health care services\, and quality of health care. She directs the federally funded UCSF Health Workforce Research Center on Long-Term Care\, which generates evidence to ensure an adequate workforce to provide patient-centered care to individuals with long-term care needs across the lifespan. She is an internationally known expert on the nursing workforce\, leading studies of nurse supply\, demand\, education\, earnings\, and contributions to the quality of care across healthcare settings. Her current research includes serving as the co-Principal Investigator for the National Dementia Workforce Study\, and leading a study of the nurse practitioners and midwives in California.
URL:https://healtheconomics.org/event/building-a-data-system-for-health-and-labor-economics-research-the-u-s-national-dementia-workforce-study/
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260302T153000
DTEND;TZID=UTC:20260302T163000
DTSTAMP:20260507T040219
CREATED:20260217T175337Z
LAST-MODIFIED:20260217T175337Z
UID:334751-1772465400-1772469000@healtheconomics.org
SUMMARY:Endogenous Screening and Health Behaviors
DESCRIPTION:Add to Calendar! \nBecause 80% of lung cancers are caused by cigarette smoking\, we build a dynamic structural model in which screening and smoking are chosen simultaneously. We estimate the model from a variety of data sources\, including novel survey information and EHR data from over 100 hospital systems. In a survey experiment\, we randomly frame screening and smoking questions\, highlighting stigma\, belief\, and price mechanisms. Informing respondents of their eligibility for free lung cancer screening under USPSTF guidelines increases intention to screen by 68.1%. We find limited effects of interventions that target a.) stigma and b.) beliefs regarding the rate of false positives. We also statistically rule out moral hazard effects with respect to screening – the idea that a clean scan may encourage further smoking. \nSpeaker: \n \nDr. Michael Darden is an Associate Professor at the Carey Business School at Johns Hopkins University. He is also a Research Faculty Fellow at the National Bureau of Economic Research and a Co-Editor at the Journal of Human Resources. Dr. Darden conducts research in health economics and health econometrics. His research has appeared in numerous academic journals\, including the Journal of Political Economy and all three major health economics journals.
URL:https://healtheconomics.org/event/endogenous-screening-and-health-behaviors/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260220T143000
DTEND;TZID=UTC:20260220T153000
DTSTAMP:20260507T040219
CREATED:20260209T183318Z
LAST-MODIFIED:20260209T183508Z
UID:334710-1771597800-1771601400@healtheconomics.org
SUMMARY:Teaching Health Economics SIG Networking Event
DESCRIPTION:Add to Calendar! \nAn interactive networking event for SIG members to exchange ideas\, discuss current themes and challenges in higher education\, and help shape future SIG activities and events. \n 
URL:https://healtheconomics.org/event/teaching-health-economics-sig-networking-event/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260202T153000
DTEND;TZID=UTC:20260202T163000
DTSTAMP:20260507T040219
CREATED:20260128T170944Z
LAST-MODIFIED:20260128T170944Z
UID:334688-1770046200-1770049800@healtheconomics.org
SUMMARY:State recreational cannabis laws and racial disparities in the criminal legal system
DESCRIPTION:Add to Calendar! \nWe estimate the direct and spillover effects of cannabis legalization on longstanding racial disparities in criminal justice outcomes. We find that legalization reduces cannabis possession and sales arrests for White and Black populations\, narrowing but not eliminating disparities. We also find spillover increases in hospitalizations involving cannabis and other illegal drugs. However\, spillovers on arrests\, incarcerations\, and crimes involving serious violent or property offenses are insignificant or even decrease. Other illegal drug sales arrests decrease across populations\, while illegal drug incarcerations decrease only among White populations. Spillovers on other low-level offenses are insignificant for White but mixed for Black populations. \nSpeaker: Angélica Meinhofer – Assistant Professor at Weill Cornell Medicine’s Department of Population Health Sciences.  \nShe specializes in health economics and applied microeconomics. Her research examines the impact of public health interventions and drug policies on the market for controlled substances. To do so\, she employs quasi-experimental methods and analyze large administrative datasets.
URL:https://healtheconomics.org/event/state-recreational-cannabis-laws-and-racial-disparities-in-the-criminal-legal-system/
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251211
DTEND;VALUE=DATE:20251213
DTSTAMP:20260507T040219
CREATED:20251116T010122Z
LAST-MODIFIED:20251116T010122Z
UID:334352-1765411200-1765583999@healtheconomics.org
SUMMARY:10th Workshop in Behavioral and Experimental Health Economics at Erasmus University Rotterdam
DESCRIPTION:Dear colleagues\, \nWe are pleased to invite submissions for the 10th Workshop in Behavioral and Experimental Health Economics at Erasmus University Rotterdam on December 11th and 12th\, 2025. The workshop is part of the activities of the Behavioral Experiments in Health Network and brings together economists and behavioral scientists who apply behavioral-economics insights and experimental methods to study health-related decision making. \nWe welcome contributions on all topics related to economic aspects of health-related decision making (e.g.\, preferences\, incentives\, institutions) applying experimental methods\, be it online\, laboratory or field experiments. We expect to have both long talks (30 min or more plus discussion) and lightning talks (5 min) that will be accompanied by a poster presentation. \nSubmissions: Please submit either the full paper\, or an extended abstract of up to 500 words that addresses each of the following: objectives\, methods\, results\, and conclusions. Preference will be given to full-paper submissions\, particularly for long talks. \nDeadline for submissions is August 30\, 2025. Submissions should be uploaded via: https://www.eur.nl/en/eshpm/events/10th-workshop-behavioral-and-experimental-health-economics-2025-12-11. \nAuthors will be notified regarding the acceptance of their paper early October 2025. \nThe keynote speaker will be W. David Bradford (University of Georgia). \nParticipation fee: There are no additional participation fees for participants with accepted presentations or posters. Accompanying persons and other interested parties should contact the event office regarding the costs. Participation is subject to availability. \nScientific committee: Silvia Angerer (UMIT Tirol)\, Arthur Attema (Erasmus U Rotterdam)\, Robert Böhm (U Vienna)\, Matteo M. Galizzi (LSE)\, Glenn W. Harrison (Georgia State U)\, Wanda Mimra (ESCP Paris)\, Matthew Robson (Erasmus U Rotterdam)\, Kirsten Rohde (University of Maastricht)\, and Daniel Wiesen (U Cologne) \nIn case you have any questions about the submisison or the event\, please contact us: behnet@eshpm.eur.nl. \nAt the same\, we also like to announce our BEHnet Winter School for PhD students\, taking place right before the Workshop\, from 8-10 December\, 2025. Please check this website for more details: https://www.eur.nl/en/eshpm/events/4th-behnet-graduate-course-behavioural-and-experimental-health-economics-2025-12-08 \nWe are looking forward to welcoming you in wonderful Rotterdam in December 2025. \nBest regards\, \nArthur\, Matthew\, and Daniel
URL:https://healtheconomics.org/event/10th-workshop-in-behavioral-and-experimental-health-economics-at-erasmus-university-rotterdam/
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20251201T153000
DTEND;TZID=UTC:20251201T163000
DTSTAMP:20260507T040219
CREATED:20251116T005422Z
LAST-MODIFIED:20251120T152530Z
UID:334350-1764603000-1764606600@healtheconomics.org
SUMMARY:The Introduction of PrEP on HIV: Incidence\, Mortality and Heterogeneity
DESCRIPTION:Add to Calendar! \nSpeaker: \n \nSebastian Tello – Associate professor of public policy and economics at the Frank Batten School of Leadership and Public Policy at the University of Virginia and a research associate at the National Bureau of Economic Research (NBER).  \nSebastian’s fields of specialization are Public Economics\, Health Economics\, and Applied Microeconomics. He has researched topics related to health insurance\, mental health\, Medicaid\, health behaviors\, and HIV. I am interested in health policy in the U.S. and Latin America. With Alex Hollingsworth\, he is the co-host of the podcast “The Hidden Curriculum”\, a podcast on topics of productivity in the economics profession. He is also involved with EconThaki\, an organization that’s helping decrease the barriers of the path for PhD in Econ by providing information and classes.
URL:https://healtheconomics.org/event/the-introduction-of-prep-on-hiv-incidence-mortality-and-heterogeneity/
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20251118T120000
DTEND;TZID=America/Toronto:20251118T130000
DTSTAMP:20260507T040219
CREATED:20251116T004513Z
LAST-MODIFIED:20251116T004513Z
UID:334345-1763467200-1763470800@healtheconomics.org
SUMMARY:Equity Informative Economic Evaluation: Networking and Mentoring Event
DESCRIPTION:Add to Calendar! \nThis one-hour\, informal session is designed to give us a chance to connect\, share what we’re working on and our research interests\, and receive feedback from group members on next steps and possible collaborations or connection.
URL:https://healtheconomics.org/event/equity-informative-economic-evaluation-networking-and-mentoring-event/
CATEGORIES:IHEA Event
END:VEVENT
END:VCALENDAR